A systematic review on immunohistochemical expression of p16, Ki67, and p53 in cervical lesions reported that nineteen out of 22 evaluated studies have shown that there is a higher p16 expression in more severe cancer lesions, while in p53 expression, only 4 out of the 9 studies showed a higher expression among more severe cases. The gene discussed is TP53; the disease is cancer.